Max Rady College of Medicine
View reference
Bernstein CN, Blanchard JF, Metge C, Yogendran M. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98(12):2784-2788. [Abstract]
Related concepts |
| Dose Intensity |
| Inflammatory Bowel Disease (IBD) - Defining in Administrative Data |
Related terms |
| Drug Program Information Network (DPIN) |
| Inflammatory Bowel Disease (IBD) |
| Prescribed Daily Dose (PDD) |
Keywords |
| IBD |
| Irritable Bowel Syndrome |
| Manitoba Studies |
Request information in an accessible format
If you require access to our resources in a different format, please contact us:
- by phone at 204-789-3819
- by email at info@cpe.umanitoba.ca
We strive to provide accommodations upon request in a reasonable timeframe.
Contact us
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada
204-789-3819